Friday, March 22, 2013

• ACT’s Chief Scientific Officer Dr. Robert Lanza to Deliver the Nerem Lecture 2013 at the 17th Annual Hilton Head WorkshopBusiness Wire (Fri, Mar 22)

Wednesday, March 20, 2013

• Phase II Trials Will Be Pivotal For These Stem Cell Companiesat Seeking Alpha (Wed, Mar 20)

Thursday, March 14, 2013

• Advanced Cell Technology Receives Approval from Data Safety Monitoring Board (DSMB) to Initiate Treatment of Third Patient Cohort in All Three Clinical TrialsBusiness Wire (Thu, Mar 14)
• 2 Biotech Stocks With Huge Potential For The Speculative Investorat Seeking Alpha (Thu, Mar 14)

Tuesday, March 12, 2013

• ACT’s Dr. Robert Lanza Voted Top 4 “Most Influential People on Stem Cells”Business Wire (Tue, Mar 12)

Friday, March 8, 2013

• Advanced Cell Technology to Present at BIO-Europe Spring 2013Business Wire (Fri, Mar 8)

Thursday, March 7, 2013

• Advanced Cell Technology's CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Mar 7)
• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 10-K, Annual ReportEDGAR Online (Thu, Mar 7)
• Advanced Cell Technology Announces Fourth-Quarter and Year-end ResultsBusiness Wire (Thu, Mar 7)

Wednesday, March 6, 2013

• Corporate Profile Advanced Cell Technology Inc.WILink (Wed, Mar 6)

Monday, March 4, 2013

• Advanced Cell Technology to Announce Fourth Quarter and Year-end Results on Thursday March 7thBusiness Wire (Mon, Mar 4)

Monday, February 11, 2013

• ACT’s Chief Scientific Officer Robert Lanza, MD, Appointed Editor-in-Chief of BioResearch Open Access JournalBusiness Wire (Mon, Feb 11)
• 2 Stem Cell Research Pioneers And Where They Are Todayat Seeking Alpha (Mon, Feb 11)
• ACT’s Clinical Partner Receives FDA Approval to Initiate Clinical Trial Using the Company’s hESC-derived Cells to Treat Severe MyopiaBusiness Wire (Mon, Feb 11)

Friday, February 8, 2013

• Advanced Cell Technology to Present at 15th Annual BIO CEO & Investor ConferenceBusiness Wire (Fri, Feb 8)
• Insight On Advanced Cell Technology: An Interview With Gary Rabin, Chairman And CEOat Seeking Alpha (Fri, Feb 8)

Friday, January 25, 2013

• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 8-K, Unregistered Sale of Equity SecuritiesEDGAR Online (Fri, Jan 25)

Tuesday, January 22, 2013

• Patients with Better Vision to be Enrolled in ACT’s Clinical Trials for Macular DegenerationBusiness Wire (Tue, Jan 22)

Friday, January 18, 2013

• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 8-K/A, Entry into a Material Definitive AgreementEDGAR Online (Fri, Jan 18)

Thursday, January 17, 2013

• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct FEDGAR Online (Thu, Jan 17)
• Advanced Cell Technology Announces Settlement of LitigationBusiness Wire (Thu, Jan 17)

Wednesday, January 9, 2013

• Stem Cell Companies For Consideration In 2013at Seeking Alpha (Wed, Jan 9)

Tuesday, January 8, 2013

• Advanced Cell Technology Achieves Clinical MilestoneBusiness Wire (Tue, Jan 8)
• Looking Beyond The JPM Global Healthcare Conference: More Biotech Than Meets The Eyeat Seeking Alpha (Tue, Jan 8)

Monday, January 7, 2013

• Advanced Cell Technology to Present at Biotech Showcase™ 2013Business Wire (Mon, Jan 7)

Add ACTC News to My Yahoo!